What is the Market's View on Scpharmaceuticals Inc (SCPH) Stock's Price and Volume Trends Wednesday?

Scpharmaceuticals Inc (SCPH) stock has risen 0.56% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Scpharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SCPH!

See Full SCPH Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SCPH Stock Today?

Scpharmaceuticals Inc (SCPH) stock is trading at $10.68 as of 10:46 AM on Wednesday, Jun 7, a loss of -$1.03, or -8.84% from the previous closing price of $11.71. The stock has traded between $10.49 and $11.50 so far today. Volume today is 295,724 compared to average volume of 325,462. To see InvestorsObserver's Sentiment Score for Scpharmaceuticals Inc click here.

More About Scpharmaceuticals Inc

scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's lead product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure. Click Here to get the full Stock Report for Scpharmaceuticals Inc stock.